Estrasorb.
Novovax Inc has developed and launched Estrasorb, a transdermally absorbed, micro-encapsulated estradiol, as an estrogen replacement therapy for short-term use in the reduction of vasomotor symptoms in menopausal women. Estrasorb was launched in the US in April 2004.
Chiechi
L Mario
LM
University of Bari, Department of Obstetrics and Gynecology, Corso Alcide de Gasperi 495, 70125 Bari, Italy. m.chiechi@gynecology3.uniba.it
D000279:Administration, Cutaneous; D002986:Clinical Trials as Topic; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy / Q000379:methods; D005260:Female; D019584:Hot Flashes / Q000188:drug therapy*; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged
D004958:Estradiol